Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy ImmuCell Corporation stock

Learn how to easily invest in ImmuCell Corporation stock.

ImmuCell Corporation is a biotechnology business based in the US. ImmuCell Corporation shares (ICCC) are listed on the NASDAQ and all prices are listed in US Dollars. ImmuCell Corporation employs 64 staff and has a trailing 12-month revenue of around $20.5 million.

How to buy shares in ImmuCell Corporation

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – ICCC – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.

ImmuCell Corporation stock price (NASDAQ: ICCC)

Use our graph to track the performance of ICCC stocks over time.

ImmuCell Corporation shares at a glance

Information last updated 2022-09-26.
Latest market close$7.71
52-week range$6.96 - $10.96
50-day moving average $8.17
200-day moving average $8.51
Wall St. target price$14.00
PE ratio 192.75
Dividend yield $0 (0%)
Earnings per share (TTM) $0.04

Buy ImmuCell Corporation shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 7 of 7
Name Product Asset types Stock trade fee Minimum deposit Signup bonus
SoFi Invest
Stocks, ETFs, Cryptocurrency
$0
$0
$10 - $100
when you open an account and place a first crypto trade of $50 - $5,000+
A free way to invest in most equities.
eToro
Stocks, ETFs, Cryptocurrency
$0
$10
8%-12% of your deposit
when you sign up and deposit at least $50. T&Cs apply.
Trade stocks in the app or online with $0 commissions. Not available in NY, NV, MN, TN, and HI.
Public
Stocks, ETFs, Cryptocurrency
$0
$0
Receive a free stock slice worth between $3–$300
when you sign up for an account and deposit at least $20.
Commission-free trading in stocks and ETFs with a social networking twist.
Tastyworks
Stocks, Options, ETFs, Cryptocurrency
$0
$0
$200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.
JPMorgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0
$0
$125 - $625
when you open and fund an account with $25,000 - $250,000+
INVESTMENT AND INSURANCE PRODUCTS ARE: NOT A DEPOSIT • NOT FDIC INSURED • NO BANK GUARANTEE • MAY LOSE VALUE
Ally Invest Self-Directed Trading
Stocks, Bonds, Options, Mutual funds, ETFs
$0
$0
$100
when you deposit or transfer $10,000–$24,900
500+ commission-free ETFs, some of the industry's lowest fees plus a cash bonus up to $3,000.
Tradier
Stocks, Options, ETFs
$0
$0
N/A
Customize your trade platform or build your own Deep tools, charts and screens Analyzers to help you study before you trade
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy ImmuCell Corporation stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

ImmuCell Corporation price performance over time

Historical closes compared with the close of $7.71 from 2022-09-23

1 week (2022-09-19) -3.38%
1 month (2022-08-26) -0.77%
3 months (2022-06-24) -8.32%
6 months (2022-03-25) -23.36%
1 year (2021-09-24) -20.43%
2 years (2020-09-25) 40.44%
3 years (2019-09-26) 41.73%
5 years (2017-09-26) 22.38%

Is ImmuCell Corporation stock undervalued or overvalued?

Valuing ImmuCell Corporation stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of ImmuCell Corporation's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

ImmuCell Corporation's P/E ratio

ImmuCell Corporation's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 193x. In other words, ImmuCell Corporation shares trade at around 193x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

ImmuCell Corporation's EBITDA

ImmuCell Corporation's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $3.1 million.

The EBITDA is a measure of a ImmuCell Corporation's overall financial performance and is widely used to measure a its profitability.

ImmuCell Corporation financials

Revenue TTM $20.5 million
Operating margin TTM 2.89%
Gross profit TTM $8.7 million
Return on assets TTM 0.82%
Return on equity TTM 0.84%
Profit margin 1.34%
Book value $4.23
Market capitalisation $59.7 million

TTM: trailing 12 months

ImmuCell Corporation share dividends

We're not expecting ImmuCell Corporation to pay a dividend over the next 12 months.

Have ImmuCell Corporation's shares ever split?

ImmuCell Corporation's shares were split on a 1:100 basis on 24 July 1990. So if you had owned 100 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your ImmuCell Corporation shares – just the quantity. However, indirectly, the new 9900% higher share price could have impacted the market appetite for ImmuCell Corporation shares which in turn could have impacted ImmuCell Corporation's share price.

ImmuCell Corporation share price volatility

Over the last 12 months, ImmuCell Corporation's shares have ranged in value from as little as $6.96 up to $10.96. A popular way to gauge a stock's volatility is its "beta".

ICCC.US volatility(beta: 0.63)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while ImmuCell Corporation's is 0.6256. This would suggest that ImmuCell Corporation's shares are less volatile than average (for this exchange).

ImmuCell Corporation overview

ImmuCell Corporation, an animal health company, develops, manufactures, and markets products that enhance the health and productivity of dairy and beef cattle in the United States and internationally. It offers First Defense, an orally delivered scours preventive product for newborn dairy and beef calves; and Tri-Shield First Defense, a passive antibody product for the treatment of E. coli, coronavirus, and rotavirus. The company also provides California Mastitis Test that is used to detect somatic cell counts in milk, as well as to determine, which quarter of the udder is mastitic; and Dual-Force First Defense, including a whey protein concentrate for the nutritional and feed supplement markets. In addition, it is involved in developing Re-Tain, a Nisin-based intramammary treatment of subclinical mastitis in lactating dairy cows. It sells its products through animal health distributors. ImmuCell Corporation was incorporated in 1982 and is headquartered in Portland, Maine.

Frequently asked questions

What percentage of ImmuCell Corporation is owned by insiders or institutions?
Currently 28.605% of ImmuCell Corporation shares are held by insiders and 14.081% by institutions.
How many people work for ImmuCell Corporation?
Latest data suggests 64 work at ImmuCell Corporation.
When does the fiscal year end for ImmuCell Corporation?
ImmuCell Corporation's fiscal year ends in December.
Where is ImmuCell Corporation based?
ImmuCell Corporation's address is: 56 Evergreen Drive, Portland, ME, United States, 04103
What is ImmuCell Corporation's ISIN number?
ImmuCell Corporation's international securities identification number is: US4525253062
What is ImmuCell Corporation's CUSIP number?
ImmuCell Corporation's Committee on Uniform Securities Identification Procedures number is: 452525306

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site